<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55207</article-id><article-id pub-id-type="doi">10.7554/eLife.55207</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-171455"><name><surname>KaramiNejadRanjbar</surname><given-names>Mohammad</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7770-2065</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-172047"><name><surname>Sharifzadeh</surname><given-names>Sahand</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172048"><name><surname>Wietek</surname><given-names>Nina C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172049"><name><surname>Artibani</surname><given-names>Mara</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172050"><name><surname>El-Sahhar</surname><given-names>Salma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-78971"><name><surname>Sauka-Spengler</surname><given-names>Tatjana</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9289-0263</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172051"><name><surname>Yau</surname><given-names>Christopher</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7615-8523</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172052"><name><surname>Tresp</surname><given-names>Volker</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-172046"><name><surname>Ahmed</surname><given-names>Ahmed A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6509-2581</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">NDWRH</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Computer science</institution>, <institution>Ludwig Maximilian University of Munich</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution content-type="dept">Weatherall Institute of Molecular Medicine</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Institute of Cancer and Genomic Sciences</institution>, <institution>University of Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-148642"><name><surname>Robles-Espinoza</surname><given-names>C Daniela</given-names></name><role>Reviewing editor</role><aff><institution>International Laboratory for Human Genome Research</institution>, <country>Mexico</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ahmed.ahmed@wrh.ox.ac.uk</email> (AA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>04</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e55207</elocation-id><history><date date-type="received"><day>16</day><month>01</month><year>2020</year></date><date date-type="accepted"><day>07</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, KaramiNejadRanjbar et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>KaramiNejadRanjbar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55207-v1.pdf"/><abstract><p>Bulk whole genome sequencing (WGS) enables the analysis of tumor evolution but, because of depth limitations, can only identify old mutational events. The discovery of current mutational processes for predicting the tumor's evolutionary trajectory requires dense sequencing of individual clones or single cells. Such studies, however, are inherently problematic because of the discovery of excessive false positive mutations when sequencing picogram quantities of DNA. Data pooling to increase the confidence in the discovered mutations, moves the discovery back in the past to a common ancestor. Here we report a robust whole genome sequencing and analysis pipeline (DigiPico/MutLX) that virtually eliminates all false positive results while retaining an excellent proportion of true positives. Using our method, we identified, for the first time, a hyper-mutation (kataegis) event in a group of ∼30 cancer cells from a recurrent ovarian carcinoma. This was unidentifiable from the bulk WGS data. Overall, we propose DigiPico/MutLX method as a powerful framework for the identification of clone-specific variants at an unprecedented accuracy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000299</institution-id><institution>Ovarian Cancer Action</institution></institution-wrap></funding-source><award-id>HER000762</award-id><principal-award-recipient><name><surname>Ahmed</surname><given-names>Ahmed A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><award-id>IS-BRC-0211-10025</award-id><principal-award-recipient><name><surname>Ahmed</surname><given-names>Ahmed A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Mohammad KaramiNejadRanjbar, AA and MK hold a patent application for DigiPico sequencing method (UK Patent Application No.  1918043.9)..</p></fn><fn fn-type="conflict" id="conf3"><p>Ahmed A Ahmed, MK and AA have filed a patent application regarding the DigiPico method (UK Patent Application No.  1918043.9)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Patients #11152, #11502 and #11513 provided written consent for participation in the prospective biomarker validation study Gynaecological Oncology Targeted Therapy Study 01 (GO-Target-01) under research ethics approval number 11/SC/0014. Patient OP1036 participated in the prospective Oxford Ovarian Cancer Predict Chemotherapy Response Trial (OXO-PCR-01), under research ethics approval number 12/SC/0404. Necessary informed consents from study participants were obtained as appropriate.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequence data has been deposited at the European Genome-phenome Archive (EGA), which is hosted by the EBI and the CRG, under accession number EGAS00001003555 (EGAD00001005118). Further information about EGA can be found on https://ega-archive.org &quot;The European Genome-phenome Archive of human data consented for biomedical research&quot;</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>KaramiNejadRanjbar M</collab><collab>Ahmed A</collab></person-group><year iso-8601-date="2019">2019</year><source>DigiPico sequencing data for the study of active mutational processes in HGSOC</source><ext-link ext-link-type="uri" xlink:href="https://ega-archive.org/datasets/EGAD00001005118">https://ega-archive.org/datasets/EGAD00001005118</ext-link><comment>European Genome-phenome Archive, EGAD00001005118</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-55207-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>